These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 31219753)

  • 1. Impaired Autonomic Nervous System-Microbiome Circuit in Hypertension.
    Zubcevic J; Richards EM; Yang T; Kim S; Sumners C; Pepine CJ; Raizada MK
    Circ Res; 2019 Jun; 125(1):104-116. PubMed ID: 31219753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota and Short Chain Fatty Acids: Influence on the Autonomic Nervous System.
    Bruning J; Chapp A; Kaurala GA; Wang R; Techtmann S; Chen QH
    Neurosci Bull; 2020 Jan; 36(1):91-95. PubMed ID: 31301036
    [No Abstract]   [Full Text] [Related]  

  • 3. Gut microbiota dysbiosis contributes to the development of hypertension.
    Li J; Zhao F; Wang Y; Chen J; Tao J; Tian G; Wu S; Liu W; Cui Q; Geng B; Zhang W; Weldon R; Auguste K; Yang L; Liu X; Chen L; Yang X; Zhu B; Cai J
    Microbiome; 2017 Feb; 5(1):14. PubMed ID: 28143587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Dysbiosis in Animals Due to Environmental Chemical Exposures.
    Rosenfeld CS
    Front Cell Infect Microbiol; 2017; 7():396. PubMed ID: 28936425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gut, Its Microbiome, and Hypertension.
    Richards EM; Pepine CJ; Raizada MK; Kim S
    Curr Hypertens Rep; 2017 Apr; 19(4):36. PubMed ID: 28444579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiome and Neuroinflammation in Hypertension.
    Richards EM; Li J; Stevens BR; Pepine CJ; Raizada MK
    Circ Res; 2022 Feb; 130(3):401-417. PubMed ID: 35113664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-Gut-Bone Marrow Axis: Implications for Hypertension and Related Therapeutics.
    Santisteban MM; Kim S; Pepine CJ; Raizada MK
    Circ Res; 2016 Apr; 118(8):1327-36. PubMed ID: 27081113
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    The Editors
    Hypertension; 2021 Apr; 77(4):e35-e41. PubMed ID: 33611938
    [No Abstract]   [Full Text] [Related]  

  • 9. Alterations of the Gut Microbiome in Hypertension.
    Yan Q; Gu Y; Li X; Yang W; Jia L; Chen C; Han X; Huang Y; Zhao L; Li P; Fang Z; Zhou J; Guan X; Ding Y; Wang S; Khan M; Xin Y; Li S; Ma Y
    Front Cell Infect Microbiol; 2017; 7():381. PubMed ID: 28884091
    [No Abstract]   [Full Text] [Related]  

  • 10. [Host-microbiota crosstalk and cardiovascular diseases].
    Amar J
    Presse Med; 2018 Sep; 47(9):775-779. PubMed ID: 29909161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut-Brain-Microbiota Axis: Antibiotics and Functional Gastrointestinal Disorders.
    Karakan T; Ozkul C; Küpeli Akkol E; Bilici S; Sobarzo-Sánchez E; Capasso R
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33513791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive hypertension: A proposed human endotype of brain/gut microbiome dysbiosis.
    Stevens BR; Pepine CJ; Richards EM; Kim S; Raizada MK
    Am Heart J; 2021 Sep; 239():27-37. PubMed ID: 33984318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics.
    Kim N; Yun M; Oh YJ; Choi HJ
    J Microbiol; 2018 Mar; 56(3):172-182. PubMed ID: 29492874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease.
    Yang T; Richards EM; Pepine CJ; Raizada MK
    Nat Rev Nephrol; 2018 Jul; 14(7):442-456. PubMed ID: 29760448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive effects of exercise involve reshaping of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rat.
    Xia WJ; Xu ML; Yu XJ; Du MM; Li XH; Yang T; Li L; Li Y; Kang KB; Su Q; Xu JX; Shi XL; Wang XM; Li HB; Kang YM
    Gut Microbes; 2021; 13(1):1-24. PubMed ID: 33382364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome and hypertension: where are we now?
    Vallianou NG; Geladari E; Kounatidis D
    J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):83-88. PubMed ID: 31809283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases.
    Ghaisas S; Maher J; Kanthasamy A
    Pharmacol Ther; 2016 Feb; 158():52-62. PubMed ID: 26627987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota-gut-brain axis: Interaction of gut microbes and their metabolites with host epithelial barriers.
    Bhattarai Y
    Neurogastroenterol Motil; 2018 Jun; 30(6):e13366. PubMed ID: 29878576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington's disease.
    Kong G; Ellul S; Narayana VK; Kanojia K; Ha HTT; Li S; Renoir T; Cao KL; Hannan AJ
    Neurobiol Dis; 2021 Jan; 148():105199. PubMed ID: 33249136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.